News for Healthier Living

Blood Test Predicts Immunotherapy Benefit Early Among Patients With Advanced Lung Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy -- a blood test that detects circulating tumor DNA (ctDNA) -- can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.

August 3, 2026


August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026